The Vietnam Cardiac Surgery Instruments Market is expected to witness growth from $10 Mn in 2022 to $18 Mn in 2030 with a CAGR of 6.83% for the forecasted year 2022-2030. Ischemic Heart Disease is becoming more common in Vietnam as the country's populace ages. The demand for cardiac surgery equipment to treat different heart conditions is rising as the population ages. The market is segmented by type, application and by end user. Some key players in this market include CPT Sutures, HCMC Medical Technical Service, LivaNova, B. Braun, Medline Industries, KLS Martin, and STILLE.
The Vietnam Artificial Intelligence (AI) In Healthcare Market is projected to grow from $0.03 Bn in 2022 to $xx Bn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. The market will be driven by the improvement in regulatory frameworks and collaboration between government, industry, and academia. The market is segmented by healthcare components & by healthcare applications. Some of the major players include GE Healthcare, IBM Watson Health & VinBrain.
The Vietnam Biomaterials in Healthcare Market is expected to witness growth from $781 Mn in 2022 to $2141 Mn in 2030 with a CAGR of 13.43% for the forecasted year 2022-2030. The demand for biomaterials in Vietnam is being driven by the rising prevalence of diseases like periodontal disease, tooth decay, oral cancer, halitosis, and dental caries, which is anticipated to spur development in the country's biomaterial healthcare market. The market is segmented by type and by application. Some key players in this market include: CPT SUTURES, J&V Medical Instrument JSC, HCMC Medical Technical Service, BASF SE, Johnson and Johnson, Medtronic and Evonik Industries.
Vietnam anti-aging therapeutics market is expected to witness growth from $3 Mn in 2022 to $10 Mn in 2030 with a CAGR of 16.76% for the forecasted year 2022-2030 due to the increasing demand for modern and innovative therapies and associated results for anti-aging treatment. The Vietnam anti-aging therapeutics market is segmented by product, treatment, target group, type of aging, type of molecules, mechanism of action, ingredient, and by distribution channel. Some of the top players in the market include Imexpharm, Ha Tay Pharmaceutical, and Biosplice.
Vietnam 3D Printing Medical Device Market is expected to witness growth from $15 Mn in 2022 to $50 Mn in 2030 with a CAGR of 16.53% for the forecasted year 2022-2030. Vietnam 3D Printing Medical Devices market has been expanding steadily in recent years due to a number of factors, including an increase in the demand for medical devices, advancements in 3D printing technology, expanding population and rising healthcare requirements and lower manufacturing costs. The market is segmented by application, by technology and by end user. Some key players in this market include: Hanoi Innovation and Technology, Nam Phong Technology, GE Healthcare, Stryker, Medtronic, Siemens Healthineers, Boston Scientific, Philips Healthcare and Stryker.
The Vietnam healthcare insurance market is projected to grow from $10.13 Bn in 2022 to $18.52 Bn by 2030, registering a CAGR of 7.83% during the forecast period of 2022 - 2030. The main factors driving the growth would be economic growth, rising middle class, urbanization and government investment. The market is segmented by component, the provider, coverage, by health insurance plans and end-user. Some of the major players include Bao Viet, PetroVietnam Insurance, Dai-ichi Life, AIA and Manulife.
Vietnam's Attention Deficit Hyperactivity Disorder (ADHD) therapeutics market is expected to witness growth from $148 Mn in 2022 to $268 Mn in 2030 with a CAGR of 7.73% for the year 2022-30. The rise in urbanization in Vietnam leading to the increased incidence of ADHD among the school-going population and increasing investments in the healthcare infrastructure are the major market drivers. The Vietnam ADHD therapeutics market is segmented by drug, drug type, demographics, and by distribution channel. ImexPharm Pharmaceutical, Binh Dinh Pharmaceutical, and Eli Lily are the leading players in the market.
The Vietnam healthcare claims management market is projected to grow from $133.5 Mn in 2022 to $728.57 Mn by 2030, registering a CAGR of 23.63% during the forecast period of 2022 - 2030. The main factors driving the growth would be government support, increasing awareness of healthcare insurance and increasing healthcare spending. The market is segmented by component, type, delivery mode and by end-user. Some of the major players include FPT Corporation, INSO, Cigna, Allianz and WellPoint.
By 2030, it is anticipated that the Vietnam Liver Disease Therapeutics market will reach a value of $183 Mn from $115 Mn in 2022, growing at a CAGR of 5.9% during 2022-2030. Liver Disease Therapeutics in Vietnam is dominated by domestic pharmaceutical companies such as Domesco, Ha Tay Pharmaceutical, and OPC. The Liver Disease Therapeutics market in Vietnam is segmented into different types of disease and different therapy types. Some of the significant factors affecting the Vietnam Liver Disease Therapeutics market are the growing prevalence of liver diseases and unhealthy and dynamic lifestyles.
Vietnam's oncology clinical trials market is projected to grow from $63.3 Mn in 2022 to $98.8 Mn by 2030, registering a CAGR of 5.73% during the forecast period of 2022-30. The market will be driven by the big and diversified patient population available for clinical trials and a well-established clinical trial regulatory structure. The market is segmented by phase, by study design & by indication. Some of the major players include AstraZeneca PLC, Novartis AG & Hau Giang Pharmaceutical Joint Stock Company.
The Vietnam Telemedicine market was valued at $304 Mn in 2022 and is estimated to expand at a compound annual growth rate (CAGR) of XX% from 2022 to 2030 and will XX Mn in 2030. One of the main reasons propelling the growth of this market is the advent of advanced technologies and government initiatives. The market is segmented by end-user, product type, and Delivery mode. Some key players in this market are Viettel group, Vietnam Posts and Telecommunications Group (VNPT), FPT Group, Doctor Anywhere, BuyMed.
The Vietnam dental care market was valued at $6.595 Bn in 2022 and is estimated to expand at a compound annual growth rate (CAGR) of 10.93% from 2022 to 2030 and will reach $15.122 Bn in 2030. One of the main reasons propelling the growth of this market demand for primary and postoperative care of higher quality, technological advancements. The market is segmented by services, by dental clinics and by revenue. Some key players in this market are Nha Khoa Kim, Nha Khoa Paris Dental Group, Nha Khoa Dang Luu, Anna Dental Care etc.
The Vietnam-connected healthcare market is projected to grow from $331.8 Mn in 2022 to $2486.65 Mn by 2030, registering a CAGR of 28.63% during the forecast period of 2022 - 2030. The main factors driving the growth would be government support, improved healthcare infrastructure, rising healthcare spending and growing demand for remote healthcare. The market is segmented by type, function and by application. Some of the major players include Viettel Group, eDoctor, Med247, Samsung, IBM and GE Healthcare.
By 2030, it is anticipated that the Vietnam oncology drugs market will reach a value of $xx Mn from $982.2 Mn in 2022, growing at a CAGR of xx% during 2022-30. The oncology drugs market in Vietnam is dominated by a few domestic pharmaceutical companies such as Vimedimex Medi-Pharma, OPC Pharmaceutical, and Hanoi Pharmaceutical. The oncology market in Vietnam is segmented into different therapeutic areas and different treatment types. The major factors affecting the Vietnam oncology drugs market are the increasing disease burden of non-communicable diseases like cancer and the lack of healthcare facilities for cancer treatment in most areas of Vietnam.
The Vietnam Neurology Device Market is expected to witness growth from $63 Mn in 2022 to $xx Bn in 2030 with a CAGR of xx% for the forecasted year 2022-2030. The Neurology devices market in Vietnam is being driven by the increase in neurological disorders like epilepsy, Parkinson's disease, and Alzheimer's disease. The market is segmented by product type and by the end user. Some key players in this market include Medtronic, Johnson and Johnson, GE Healthcare, Stryker, Abbott laboratories and Philips Healthcare.
Vietnam's patient engagement solutions market is projected to grow from $85.05 Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022-30. The main factors driving the growth would be increasing healthcare spending, an aging population, and government support. The market is segmented by component, delivery mode, application, therapeutic area, functionality, and by end-user. Some of the major players include Oracle, Siemens Healthineers, IBM, and others.
The Vietnam Neurology Clinical Trials market is projected to grow from $26.2 Mn in 2022 to $40.8 Mn by 2030, registering a CAGR of 5.73% during the forecast period of 2022 - 2030. The market will be driven by the rising frequency of neurological illnesses such as Alzheimer's, Parkinson's, and stroke along with improving healthcare infrastructure in Vietnam. The market is segmented by phase, by study design & by indication. Some of the major players include Biogen, Pfizer Inc. & Vietnam Pharmaceutical Corporation.
By 2030, it is anticipated that the Vietnam infectious disease therapeutics market will reach a value of $857.57 from $599.35 Mn in 2022, growing at a CAGR of 4.6% during 2022-2030. Infectious Disease Therapeutics in Vietnam is dominated by a few domestic pharmaceutical companies such as Hau Giang Pharmaceutical, Domesco Medical and OPC Pharmaceutical. The Infectious Disease Therapeutics market in Vietnam is segmented into different therapeutic areas and different diseases type. The major factors affecting the Vietnam infectious disease therapeutics market are the increasing disease burden of communicable diseases like TB, hepatitis, and COVID-19 and the amount of healthcare funding for infectious disease treatment in various areas of Vietnam.
Vietnam's Artificial Intelligence (AI) in the diagnostics market is projected to grow from $5.0 Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022-30. The market will be driven by the rising incidence of chronic diseases and expanded investments in the AI Diagnostic industry. The market is segmented by component & by diagnosis. Some of the major players include IBM Watson Health, Siemens Healthineers & Genetica.
The Vietnam 3D Imaging market is projected to grow from $0.15 Bn in 2022 to $xx Bn by 2030, registering a CAGR xx% during the forecast period of 2022 - 2030. The market will be driven by the growing need for modern medical technology, greater emphasis on enhancing healthcare services, and rising investments in cutting-edge medical technology. The market is segmented by product, by application, end-user & by portability. Some of the major players include GE Healthcare, Siemens Healthineers & FPT Corporation
By 2030, it is anticipated that the Vietnam HIV therapeutics market will reach a value of $xx Mn from $68.8 Mn in 2022, growing at a CAGR of xx% during 2022-2030. The market is primarily dominated by local players such as Vihado Joint Stock Company, Imexpharm Pharmaceutical, and Viet-AID. The market is driven by the management of HIV infections, high out-of-pocket expenditure, and the healthcare infrastructure of the country. The HIV therapeutics market in Vietnam is segmented by type, product, and geography, end user, and distribution channel.
By 2030, it is anticipated that the Vietnam Dermatology drugs market will reach a value of $xx Mn from $85 Mn in 2022, growing at a CAGR of xx% during 2022-2030. The market is primarily dominated by local players such as Traphaco, Pymepharco, and Imexpharm. The market is driven by the prevalence of dermatology conditions, awareness about dermatological health, and increasing healthcare spending. The dermatology drug market in Vietnam is segmented by drug class, drug type, prescription mode, indication, route of administration, end user, and distribution channel.
The Vietnam Palliative care market is projected to grow from $65.4 Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. The main factors driving the growth would be improving the healthcare industry, growing awareness about palliative care, the rapidly aging population, and the increasing prevalence of chronic diseases. The market is segmented by service type and by the end user. Some of the major players include Bach Mai Hospital, FV Hospital, Cho Ray Hospital, and Hue Central Hospital.
By 2030, it is anticipated that the Vietnam Nutrition and Supplements market will reach a value of $xx Bn from $1.91 Bn in 2022, growing at a CAGR of xx% during 2022-2030. The market is primarily dominated by local players such as DHA Group, Vina Pharma, and Greenlife Nutrition. The market for nutrition and supplements in Vietnam is primarily driven by an inclination towards imported products and increasing consumer awareness of health and lifestyle. The Vietnam nutrition and supplements market in Vietnam is segmented by Type, Product, application, and Distribution Channel.
The Vietnam home healthcare market was valued at $1.813 Bn in 2022 and is estimated to expand at a compound annual growth rate (CAGR) of 7.93% from 2022 to 2030 and will reach $3.34 Bn in 2030. One of the main reasons propelling the growth of this market is the introduction of newer technologies, and the aging population. The market is segmented by components and services. Some key players in this market are FPT Healthcare, Family Medical Practice, Viet Phap Hospital, Tam Duc Heart Hospital, Hoan My Medical Corporation, International SOS Vietnam, and VietCare Medical Services.